
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8114783
[patent_doc_number] => 08158613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'Topical pharmaceutical formulations and methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 12/832907
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13491
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12832907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/832907 | Topical pharmaceutical formulations and methods of treatment | Jul 7, 2010 | Issued |
Array
(
[id] => 6388514
[patent_doc_number] => 20100317671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'XANTHINE-BASED CYCLIC GMP-ENHANCING RHO-KINASE INHIBITOR INHIBITS PHYSIOLOGICAL ACTIVITIES OF LUNG EPITHELIAL CELL LINE'
[patent_app_type] => utility
[patent_app_number] => 12/831544
[patent_app_country] => US
[patent_app_date] => 2010-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13933
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317671.pdf
[firstpage_image] =>[orig_patent_app_number] => 12831544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/831544 | XANTHINE-BASED CYCLIC GMP-ENHANCING RHO-KINASE INHIBITOR INHIBITS PHYSIOLOGICAL ACTIVITIES OF LUNG EPITHELIAL CELL LINE | Jul 6, 2010 | Abandoned |
Array
(
[id] => 8516795
[patent_doc_number] => 20120316203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'Compositions and Methods for Inhibition of Cancers'
[patent_app_type] => utility
[patent_app_number] => 13/382545
[patent_app_country] => US
[patent_app_date] => 2010-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16890
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382545 | Compositions and Methods for Inhibition of Cancers | Jul 5, 2010 | Abandoned |
Array
(
[id] => 6388669
[patent_doc_number] => 20100317687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => '2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/828379
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7700
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317687.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828379 | 2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | Jun 30, 2010 | Abandoned |
Array
(
[id] => 8503210
[patent_doc_number] => 20120302618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'USE OF BENZYDAMINE IN THE TREATMENT OF P40-DEPENDENT DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/382450
[patent_app_country] => US
[patent_app_date] => 2010-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3964
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382450
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382450 | USE OF BENZYDAMINE IN THE TREATMENT OF P40-DEPENDENT DISEASES | Jun 22, 2010 | Abandoned |
Array
(
[id] => 6518737
[patent_doc_number] => 20100261791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Compositions and Methods for Improving or Preserving Brain Function'
[patent_app_type] => utility
[patent_app_number] => 12/821401
[patent_app_country] => US
[patent_app_date] => 2010-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23434
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261791.pdf
[firstpage_image] =>[orig_patent_app_number] => 12821401
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/821401 | Compositions and Methods for Improving or Preserving Brain Function | Jun 22, 2010 | Abandoned |
Array
(
[id] => 6618129
[patent_doc_number] => 20100324059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING HCV'
[patent_app_type] => utility
[patent_app_number] => 12/818407
[patent_app_country] => US
[patent_app_date] => 2010-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5699
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324059.pdf
[firstpage_image] =>[orig_patent_app_number] => 12818407
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/818407 | PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING HCV | Jun 17, 2010 | Abandoned |
Array
(
[id] => 8160250
[patent_doc_number] => 20120101083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'S1P1 AGONISTS COMPRISING A BICYCLIC N-CONTAINING RING'
[patent_app_type] => utility
[patent_app_number] => 13/379059
[patent_app_country] => US
[patent_app_date] => 2010-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107220
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101083.pdf
[firstpage_image] =>[orig_patent_app_number] => 13379059
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/379059 | S1P1 AGONISTS COMPRISING A BICYCLIC N-CONTAINING RING | Jun 16, 2010 | Abandoned |
Array
(
[id] => 8725630
[patent_doc_number] => 08404748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Storage-stable formulation of paracetamol in aqueous solution'
[patent_app_type] => utility
[patent_app_number] => 12/797478
[patent_app_country] => US
[patent_app_date] => 2010-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4310
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797478
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/797478 | Storage-stable formulation of paracetamol in aqueous solution | Jun 8, 2010 | Issued |
Array
(
[id] => 6196724
[patent_doc_number] => 20110028482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE'
[patent_app_type] => utility
[patent_app_number] => 12/782655
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51024
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12782655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782655 | Isoxazolines as inhibitors of fatty acid amide hydrolase | May 17, 2010 | Issued |
Array
(
[id] => 8221825
[patent_doc_number] => 20120136033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/321293
[patent_app_country] => US
[patent_app_date] => 2010-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22457
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321293
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321293 | Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof | May 16, 2010 | Abandoned |
Array
(
[id] => 10032610
[patent_doc_number] => 09073917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Anti-cancer compound and pharmaceutical composition containing the same'
[patent_app_type] => utility
[patent_app_number] => 13/320965
[patent_app_country] => US
[patent_app_date] => 2010-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7179
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320965
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320965 | Anti-cancer compound and pharmaceutical composition containing the same | May 16, 2010 | Issued |
Array
(
[id] => 6569108
[patent_doc_number] => 20100234416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'USE OF HUPERZINE FOR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/779612
[patent_app_country] => US
[patent_app_date] => 2010-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17554
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234416.pdf
[firstpage_image] =>[orig_patent_app_number] => 12779612
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/779612 | Use of huperzine for disorders | May 12, 2010 | Issued |
Array
(
[id] => 6196808
[patent_doc_number] => 20110028566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'COMPOSITIONS AND PRODUCTS CONTAINING CYCLOALIPHATIC DIOL ANTIMICROBIAL AGENTS AND METHODS OF USING THE COMPOSITIONS AND PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 12/779164
[patent_app_country] => US
[patent_app_date] => 2010-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29249
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12779164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/779164 | COMPOSITIONS AND PRODUCTS CONTAINING CYCLOALIPHATIC DIOL ANTIMICROBIAL AGENTS AND METHODS OF USING THE COMPOSITIONS AND PRODUCTS | May 12, 2010 | Abandoned |
Array
(
[id] => 6496387
[patent_doc_number] => 20100286101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'PHARMACEUTICAL COMPOSITION INCLUDING A CORTICOSTEROID AND A VITAMIN D ANALOG HAVING IMPROVED STABILITY'
[patent_app_type] => utility
[patent_app_number] => 12/776111
[patent_app_country] => US
[patent_app_date] => 2010-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10878
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286101.pdf
[firstpage_image] =>[orig_patent_app_number] => 12776111
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776111 | PHARMACEUTICAL COMPOSITION INCLUDING A CORTICOSTEROID AND A VITAMIN D ANALOG HAVING IMPROVED STABILITY | May 6, 2010 | Abandoned |
Array
(
[id] => 8435572
[patent_doc_number] => 08283341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-09
[patent_title] => 'Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process'
[patent_app_type] => utility
[patent_app_number] => 12/776217
[patent_app_country] => US
[patent_app_date] => 2010-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7720
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12776217
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776217 | Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process | May 6, 2010 | Issued |
Array
(
[id] => 6515405
[patent_doc_number] => 20100216784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/770091
[patent_app_country] => US
[patent_app_date] => 2010-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 38102
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216784.pdf
[firstpage_image] =>[orig_patent_app_number] => 12770091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/770091 | Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds | Apr 28, 2010 | Abandoned |
Array
(
[id] => 6501374
[patent_doc_number] => 20100215735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/770071
[patent_app_country] => US
[patent_app_date] => 2010-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 38135
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215735.pdf
[firstpage_image] =>[orig_patent_app_number] => 12770071
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/770071 | Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds | Apr 28, 2010 | Abandoned |
Array
(
[id] => 6578261
[patent_doc_number] => 20100273894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'TREATMENT OF LEBER\'S HEREDITARY OPTIC NEUROPATHY AND DOMINANT OPTIC ATROPHY WITH TOCOTRIENOL QUINONES'
[patent_app_type] => utility
[patent_app_number] => 12/768565
[patent_app_country] => US
[patent_app_date] => 2010-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17719
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273894.pdf
[firstpage_image] =>[orig_patent_app_number] => 12768565
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/768565 | TREATMENT OF LEBER'S HEREDITARY OPTIC NEUROPATHY AND DOMINANT OPTIC ATROPHY WITH TOCOTRIENOL QUINONES | Apr 26, 2010 | Abandoned |
Array
(
[id] => 10154601
[patent_doc_number] => 09186353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-17
[patent_title] => 'Treatment of osteoarthritis pain'
[patent_app_type] => utility
[patent_app_number] => 12/767608
[patent_app_country] => US
[patent_app_date] => 2010-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15619
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12767608
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/767608 | Treatment of osteoarthritis pain | Apr 25, 2010 | Issued |